UKIACR average (population) | UKIACR average (country) | England | Scotland | Wales | Northern Ireland | Republic of Ireland | |
---|---|---|---|---|---|---|---|
All invasive xnmsc | 1.4% | 1.3% | 1.5% | 0.8% | 2.2% | 0.6% | 1.6% |
All xnmsc 0-24 | 0.3% | 0.3% | 0.3% | 0.3% | 0.0% | 0.0% | 1.0% |
All xnmsc 25-59 | 0.3% | 0.3% | 0.4% | 0.2% | 0.4% | 0.2% | 0.3% |
All xnmsc 60-79 | 1.0% | 0.9% | 1.0% | 0.7% | 1.3% | 0.6% | 1.1% |
All xnmsc 80+ | 3.9% | 3.8% | 3.9% | 1.7% | 6.0% | 1.4% | 6.0% |
All registrations | 1.0% | 0.9% | 1.0% | 0.5% | 1.6% | 0.3% | 0.9% |
Haematology | 1.6% | 1.5% | 1.7% | 0.4% | 2.8% | 0.6% | 1.7% |
Head and Neck | 0.5% | 0.5% | 0.5% | 0.0% | 1.2% | 0.0% | 0.7% |
Lower GI | 1.3% | 1.2% | 1.4% | 0.7% | 1.5% | 0.6% | 1.8% |
Upper GI | 1.7% | 1.5% | 1.7% | 0.8% | 2.5% | 0.5% | 2.1% |
HPB | 2.9% | 2.7% | 3.0% | 1.4% | 3.8% | 1.0% | 4.0% |
Trachea, Bronchus & Lung | 2.1% | 1.9% | 2.3% | 1.1% | 2.7% | 1.2% | 2.3% |
Melanoma | 0.1% | 0.0% | 0.1% | 0.0% | 0.1% | 0.0% | 0.0% |
Breast | 0.4% | 0.4% | 0.4% | 0.2% | 0.9% | 0.1% | 0.2% |
Cervix | 0.4% | 0.7% | 0.4% | 0.5% | 0.0% | 2.5% | 0.0% |
Other Female Genitals | 1.1% | 1.0% | 1.1% | 0.4% | 1.7% | 0.2% | 1.6% |
Prostate | 0.7% | 0.6% | 0.7% | 0.2% | 1.1% | 0.1% | 0.9% |
Kidney | 1.5% | 1.2% | 1.6% | 1.4% | 1.1% | 0.0% | 2.1% |
Bladder | 1.5% | 1.0% | 1.6% | 0.6% | 1.4% | 0.0% | 1.6% |
Brain and CNS | 1.4% | 1.3% | 1.4% | 0.7% | 1.4% | 0.0% | 3.2% |
Thyroid & other endocrine glands | 0.8% | 1.0% | 0.7% | 1.0% | 0.8% | 1.1% | 1.4% |
CUP | 8.3% | 8.3% | 8.4% | 5.1% | 14.1% | 5.5% | 8.4% |
Other invasive cancer | 2.5% | 3.2% | 2.4% | 1.8% | 5.8% | 3.0% | 2.8% |
Breast in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Other tumours | 1.0% | 0.6% | 1.3% | 0.2% | 1.5% | 0.1% | 0.0% |